QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
A recent study presented at the European Society for Medical Oncology (ESMO) Congress in 2023 discussed a new treatment for patients with advanced prostate cancer. The research, led by Dr. William K. Kelly, examined the use of a treatment called…
Pathogenic germline mutations in certain genes can increase the risk of aggressive prostate cancer (PC). Researchers sought to find out how common these mutations are in men with low-risk PC who are under active surveillance. The authors also wanted to…
A recent study suggests that differences in outcomes by race and ethnicity among men with nonmetastatic castration-resistant prostate cancer (nmCRPC) exist but can be reduced with equal access to care. Researchers from the University of Utah analyzed clinical outcomes for…
Considering the possible association between obesity (e.g., metabolic syndrome) and the development and progression of prostate cancer, metformin, a medicine commonly used to treat diabetes, could be considered for use alone or in combination with other treatments to reduce the…
The risk for prostate cancer and its more aggressive forms have been associated with obesity (i.e., the metabolic syndrome), and generally, men are encouraged to lose weight to reduce this risk factor. Recently, several anti-diabetes drugs have become increasingly popular…
In cancer treatment, adjuvant therapy plays a crucial role in reducing the chances of cancer recurrence and, in some cases, improving the odds of a cure. Over the past decade, various studies have examined the use of adjuvant therapy for…
Before the use of prostate biopsy alone to detect prostate cancer, MRI was used as a tool for local staging and as a component of active surveillance (AS). Recently, MRI has been seen as a valuable tool for improving assessments…
Between 2004 and 2020, there was a notable change in how doctors treated prostate cancer in the US, as reported in JAMA Oncology. A research team studied data from the National Cancer Database involving 313,062 patients with localized prostate cancer….
Black men benefit more from prostate cancer screening in general and from personalized biomarkers because they are more likely to harbor genomically-aggressive cancer, even if it appears they have low-risk disease. Prostate cancer mortality rates in Black men are approximately…
In 2016, the Center for Medical Disease reduced the fee for robotic prostatectomy by 33%. The authors hypothesized that adjunct procedures would be added. There is research that the procedure of urethral suspension may accelerate continence recovery, but it is…
"*" indicates required fields
